Shopping Cart
- Remove All
- Your shopping cart is currently empty
LDN-193189 Tetrahydrochloride (DM-3189 Tetrahydrochloride) is a selective inhibitor of BMP type I receptors, inhibiting ALK2 and ALK3 (IC₅₀ = 5/30 nM), with weaker activity against ALK4, ALK5, and ALK7, and can be used for research into progressive osseous fibrodysplasia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $63 | In Stock | |
5 mg | $143 | In Stock | |
10 mg | $212 | In Stock | |
25 mg | $357 | In Stock | |
50 mg | $531 | In Stock | |
100 mg | $758 | In Stock | |
200 mg | $1,020 | In Stock |
Description | LDN-193189 Tetrahydrochloride (DM-3189 Tetrahydrochloride) is a selective inhibitor of BMP type I receptors, inhibiting ALK2 and ALK3 (IC₅₀ = 5/30 nM), with weaker activity against ALK4, ALK5, and ALK7, and can be used for research into progressive osseous fibrodysplasia. |
Targets&IC50 | ACVR1:5 nM, BMPR1A:7 nM |
In vitro | LDN-193189 Tetrahydrochloride potently inhibits the kinase activity of ALK4 and ActRIIA with IC50 values of 101 and 210 nM, respectively.[2] |
In vivo | Methods: SCID mice bearing MDA-PCa-118b tumor xenografts were treated with LDN-193189 Tetrahydrochloride (3 mg/kg, intraperitoneal injection, twice daily). Tumor size and body weight were measured weekly to investigate the effect of LDN-193189 Tetrahydrochloride on tumor growth in vivo. Results: Treatment of MDA-PCa-118b tumor-bearing mice with LDN-193189 Tetrahydrochloride resulted in decreased bone formation and attenuated tumor growth. [1] |
Synonyms | LDN193189 Tetrahydrochloride, DM-3189 Tetrahydrochloride, DM3189 Tetrahydrochloride |
Molecular Weight | 552.33 |
Formula | C25H26Cl4N6 |
Cas No. | 2310134-98-4 |
Smiles | C1(C2=C3N=CC(C4=CC=C(N5CCNCC5)C=C4)=CN3N=C2)=C6C=CC=CC6=NC=C1.Cl.Cl.Cl.Cl |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 3.3 mg/mL (5.97 mM), Sonication is recommended. H2O: 25 mg/mL (45.26 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO/H2O
H2O
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.